Sarepta Therapeutics (SRPT) PT Lowered to $75 at Needham & Company; 'FY17 Guidance Significantly Below Expectations'

Go back to Sarepta Therapeutics (SRPT) PT Lowered to $75 at Needham & Company; 'FY17 Guidance Significantly Below Expectations'
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 22.50 -0.49 (2.13%)
Previous Close $22.99    52 Week High $63.73 
Open $22.58    52 Week Low $8.00 
Day High $22.65    P/E N/A 
Day Low $21.98    EPS $-5.69 
Volume 2,955,534